Correlation Between Caribou Biosciences and ACELYRIN, INC

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Caribou Biosciences and ACELYRIN, INC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Caribou Biosciences and ACELYRIN, INC into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Caribou Biosciences and ACELYRIN, INC Common, you can compare the effects of market volatilities on Caribou Biosciences and ACELYRIN, INC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Caribou Biosciences with a short position of ACELYRIN, INC. Check out your portfolio center. Please also check ongoing floating volatility patterns of Caribou Biosciences and ACELYRIN, INC.

Diversification Opportunities for Caribou Biosciences and ACELYRIN, INC

0.41
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Caribou and ACELYRIN, is 0.41. Overlapping area represents the amount of risk that can be diversified away by holding Caribou Biosciences and ACELYRIN, INC Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ACELYRIN, INC Common and Caribou Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Caribou Biosciences are associated (or correlated) with ACELYRIN, INC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ACELYRIN, INC Common has no effect on the direction of Caribou Biosciences i.e., Caribou Biosciences and ACELYRIN, INC go up and down completely randomly.

Pair Corralation between Caribou Biosciences and ACELYRIN, INC

Given the investment horizon of 90 days Caribou Biosciences is expected to generate 1.01 times more return on investment than ACELYRIN, INC. However, Caribou Biosciences is 1.01 times more volatile than ACELYRIN, INC Common. It trades about -0.03 of its potential returns per unit of risk. ACELYRIN, INC Common is currently generating about -0.1 per unit of risk. If you would invest  196.00  in Caribou Biosciences on September 29, 2024 and sell it today you would lose (29.00) from holding Caribou Biosciences or give up 14.8% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Caribou Biosciences  vs.  ACELYRIN, INC Common

 Performance 
       Timeline  
Caribou Biosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Caribou Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's fundamental drivers remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.
ACELYRIN, INC Common 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ACELYRIN, INC Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Caribou Biosciences and ACELYRIN, INC Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Caribou Biosciences and ACELYRIN, INC

The main advantage of trading using opposite Caribou Biosciences and ACELYRIN, INC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Caribou Biosciences position performs unexpectedly, ACELYRIN, INC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ACELYRIN, INC will offset losses from the drop in ACELYRIN, INC's long position.
The idea behind Caribou Biosciences and ACELYRIN, INC Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Complementary Tools

Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume